Dr. Mark Dybul, former Executive Director of the Global Fund and U.S. Global AIDS Coordinator, Appointed to the Board of Directors of MSH

Leading health systems strengthening organization welcomes distinguished global health leader and innovator to its Board

Medford, Mass – Management Sciences for Health (MSH) today announced the appointment of the Honorable Mark Dybul, MD, to its Board of Directors. Dr. Dybul is the Faculty Co-Director of the Center for Global Health and Quality and Professor in the Department of Medicine at Georgetown University Medical Center.

From 2012-17, Dr. Dybul served as Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. Dr. Dybul previously served as U.S. Global AIDS Coordinator, overseeing the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) from 2006-09, where he had also served as Chief Medical officer, Assistant, Deputy and Acting Director.

“Over the last 15 years, the global health sector has made extraordinary progress in combating important diseases, and Mark Dybul has been a true leader in these vital efforts,” said Lawrence K. Fish, Chairman of the MSH Board of Directors. “We are excited to bring Mark’s vision, passion and experience to MSH, as we seek to build a world where everyone has the opportunity to live a healthy life.”

Marian Wentworth, President and CEO of MSH, added: “To achieve equitable, affordable access to high quality health services for all who need them demands innovation: including harnessing the potential of data and technology, engaging the private sector, and advocating for effective, sustainable healthcare policies. Mark brings with him the experience of having designed and led the most effective and impactful global health organizations today. We know his guidance will be instrumental in MSH’s continued leadership in global health system strengthening.”

In his role at Georgetown’s Center for Global Health and Quality, Dr. Dybul oversees a multi-disciplinary enterprise that seeks to transform the financing and delivery of healthcare in low-resource settings by combining evidence-based strategies with world-class data, business and management practices.

“At both PEPFAR and the Global Fund, I witnessed and have long-admired the efforts of MSH in working shoulder-to-shoulder with communities to strengthen health systems around the globe,” said Dr. Dybul. “From combating the spread of HIV, malaria and tuberculosis, to helping prevent the recurrence of epidemics such as Ebola, the organization has continually demonstrated the drive to do what it takes to be at the leading edge of addressing the biggest healthcare challenges of today to prevent the infectious diseases of tomorrow. I look forward to being a partner in accomplishing their mission as I join the MSH Board of Directors.”

Printer Friendly VersionPDF